Inpart Logo
Campaign Preview

Toll-Like Receptor Agonist Programme for Tumour Immunotherapy [2026-09-25 06:39]

13 Days Left

Opportunity types being sought:

Biopharma Assets
Technologies
Research Projects
Header

Pipeline scoping test campaign content